|
Volumn 1160, Issue 1-2, 2007, Pages 263-269
|
Study on the quality control of cell therapy products. Determination of N-glycolylneuraminic acid incorporated into human cells by nano-flow liquid chromatography/Fourier transformation ion cyclotron mass spectrometry
|
Author keywords
Cell therapy products; Fourier transformation ion cyclotron mass spectrometry; N Glycolylneuraminic acid; Nano flow liquid chromatography
|
Indexed keywords
CELL THERAPY PRODUCTS;
N-GLYCOLYLNEURAMINIC ACID;
NANO-FLOW LIQUID CHROMATOGRAPHY;
CYCLOTRON RESONANCE;
FOURIER TRANSFORM INFRARED SPECTROSCOPY;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
QUALITY CONTROL;
SUGARS;
CELLS;
1,2 DIAMINO 4,5 METHYLENEDIOXYBENZENE;
1,3 BENZODIOXOLE DERIVATIVE;
N GLYCOLOYLNEURAMINIC ACID;
SIALIC ACID;
UNCLASSIFIED DRUG;
ARTICLE;
CELL THERAPY;
CHEMICAL ANALYSIS;
CONTAMINATION;
EMBRYONIC STEM CELL;
HUMAN;
HUMAN CELL;
IMMUNOGENICITY;
ION CYCLOTRON RESONANCE MASS SPECTROMETRY;
LIQUID CHROMATOGRAPHY;
NANOANALYSIS;
NANOFLOW LIQUID CHROMATOGRAPHY;
PRIORITY JOURNAL;
QUALITY CONTROL;
SAFETY;
TREATMENT OUTCOME;
CALIBRATION;
CELL MEMBRANE;
CHROMATOGRAPHY, LIQUID;
CYCLOTRONS;
FOURIER ANALYSIS;
HL-60 CELLS;
HUMANS;
MASS SPECTROMETRY;
N-ACETYLNEURAMINIC ACID;
NANOTECHNOLOGY;
NEURAMINIC ACIDS;
QUALITY CONTROL;
SUBCELLULAR FRACTIONS;
TISSUE THERAPY;
ANIMALIA;
BOS;
MUS;
|
EID: 34447527616
PISSN: 00219673
EISSN: None
Source Type: Journal
DOI: 10.1016/j.chroma.2007.05.062 Document Type: Article |
Times cited : (26)
|
References (23)
|